Keytruda Hangs On to Best Seller Crown as GLP-1s Gain Ground

By /

Merck’s Keytruda will soon lose exclusivity, just as weight-loss giants Eli Lilly and Novo Nordisk press in with their blockbuster GLP-1s.

Scroll to Top